The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study

Acta Psychiatrica Scandinavica
V TapiainenAnna-Maija Tolppanen

Abstract

To assess the association between benzodiazepine and related drug (BZDR) use and risk of Alzheimer's disease (AD) with cumulative consumption and duration of use based models. A nationwide nested case-control study of all Finnish community-dwelling persons who received clinically verified AD diagnosis in 2005-2011 (N = 70 719) and their matched controls (N = 282 862). AD diagnosis was based on DSM-IV and NINCDS-ADRDA criteria. BZDR purchases were extracted from the Prescription Register since 1995. The association between BZDR use and AD was assessed using conditional logistic regression with 5-year lag time between exposure and outcome. Benzodiazepine and related drug use was associated with modestly increased risk of AD (adjusted OR 1.06, 95% CI 1.04-1.08). A dose-response relationship was observed with both cumulative consumption and duration. Adjustment for other psychotropics removed the cumulative dose-response relationship by attenuating the ORs in the highest dose category. Benzodiazepine and related drug use in general was associated with modestly increased risk of AD. No major differences were observed between different subcategories of BZDRs (i.e. benzodiazepines, Z drugs, short-/medium-acting or long-acting BZDRs). ...Continue Reading

References

May 1, 1990·Anesthesiology·M M Ghoneim, S P Mewaldt
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·R G Lister
Apr 16, 1998·Alzheimer Disease and Associated Disorders·J FastbomB Winblad
Jan 29, 2002·Current Pharmaceutical Design·S E Buffett-Jerrott, S H Stewart
Sep 25, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Shelly L GrayAndrea Z LaCroix
Feb 18, 2005·International Psychogeriatrics·Michael LindenHanfried Helmchen
Nov 4, 2006·Pharmacoepidemiology and Drug Safety·P Carrasco-GarridoA Gil de Miguel
Aug 30, 2007·Australian and New Zealand Journal of Public Health·Alice WindleVivienne Moore
Dec 11, 2008·Annals of Neurology·Hélène AmievaJean François Dartigues
Apr 20, 2013·JAMA Neurology·Edo RichardJosé A Luchsinger
Jul 16, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Alina SolomonTiina Laatikainen
Mar 13, 2014·Current Opinion in Psychiatry·Florindo StellaOrestes V Forlenza
May 13, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sep 12, 2014·BMJ : British Medical Journal·Sophie Billioti de GageBernard Bégaud
Dec 18, 2014·JAMA Psychiatry·Mark OlfsonMichael Schoenbaum
Apr 19, 2015·BMC Medical Informatics and Decision Making·Antti TanskanenJari Tiihonen
May 29, 2015·PloS One·GuoChao ZhongYong Zhao
Jul 1, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Patrick ImfeldChristoph R Meier
Oct 10, 2015·The British Journal of Psychiatry : the Journal of Mental Science·Marjaana KoponenSirpa Hartikainen
Nov 26, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Dalia ShashChristophe Tzourio
Feb 4, 2016·BMJ : British Medical Journal·Shelly L GrayEric B Larson
Mar 1, 2016·International Journal of Geriatric Psychiatry·Arto PuranenSirpa Hartikainen
Jul 15, 2016·BMJ Open·Anna-Maija TolppanenSirpa Hartikainen
Aug 29, 2016·Journal of Alzheimer's Disease : JAD·Willy GommBritta Haenisch
Oct 19, 2016·Clinical Therapeutics·Jennifer L SchroeckKari A Mergenhagen

❮ Previous
Next ❯

Citations

Feb 5, 2019·British Journal of Pharmacology·Romain BarusRégis Bordet
Jul 16, 2020·Clinics·Angela Maria CampanhaLaura Helena Andrade
Jan 24, 2020·Frontiers in Aging Neuroscience·Miren EttchetoAntonio Camins
Feb 7, 2020·Current Treatment Options in Neurology·Luigi Ferini-StrambiMaria Salsone
Nov 7, 2018·Acta Psychiatrica Scandinavica·M B Jørgensen, M Osler
Sep 6, 2020·Scientific Reports·Hélène Jacqmin-GaddaPierre Joly
May 22, 2020·Medicina clínica·Pablo AldazMa José Ariz
Oct 13, 2019·Journal of the American Medical Directors Association·Adam H DyerUNKNOWN NILVAD Study Group
Jul 30, 2021·Ageing Research Reviews·Doortje W DekensPetrus J W Naudé
Jun 12, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Christopher N KaufmannAtul Malhotra
Aug 17, 2021·The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa·Karishma Lowton, Gaveeta Chiba
Oct 23, 2021·British Journal of Clinical Pharmacology·Asma AlDawsariAmanj Kurdi
Nov 3, 2021·The International Journal of Neuropsychopharmacology·Francisco Torres-BondiaGerard Piñol-Ripoll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The American Journal of Gastroenterology
Heidi TaipaleS Hartikainen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Heidi TaipaleSirpa Hartikainen
Journal of the American Medical Directors Association
Laura SaarelainenHeidi Taipale
© 2022 Meta ULC. All rights reserved